✨ Your Portfolio is fetched and updated from zerodha.
Nano Hospitals

Vaidya Sane Ayurved Laboratories Ltd.

MADHAVBAUG

Market Cap
₹194 Cr.
P/E
27.26

Vaidya Sane Ayurved Laboratories Ltd.

  • Vaidya Sane Ayur Lab
  • Ambalal Sarabhai Ent
  • Gennex Lab

FAQs on Vaidya Sane Ayurved Laboratories Ltd. Shareprice

Vaidya Sane Ayur Lab has given lower returns compared to its competitors.
Vaidya Sane Ayur Lab has grown at ~-4.3% over the last 3yrs while peers have grown at a median rate of 2.34%

Vaidya Sane Ayur Lab is not expensive.
Latest PE of Vaidya Sane Ayur Lab is 29.61, while 3 year average PE is 56.08.
Also latest EV/EBITDA of Vaidya Sane Ayur Lab is 9.5 while 3yr average is 13.19.

View FAQ's On Business

Growth Table

  • Vaidya Sane Ayurved Laboratories Ltd.
  • Ambalal Sarabhai Ent
  • Gennex Lab

Balance Sheet

  • Vaidya Sane Ayurved Laboratories Ltd.
  • Ambalal Sarabhai Ent
  • Gennex Lab

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Vaidya Sane Ayurved Laboratories Ltd.
  • Ambalal Sarabhai Ent
  • Gennex Lab

Cash Flow

  • Vaidya Sane Ayurved Laboratories Ltd.
  • Ambalal Sarabhai Ent
  • Gennex Lab

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Vaidya Sane Ayurved Laboratories Ltd.
  • Ambalal Sarabhai Ent
  • Gennex Lab

Quarterly Results

  • Vaidya Sane Ayurved Laboratories Ltd.
  • Ambalal Sarabhai Ent
  • Gennex Lab

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Vaidya Sane Ayurved Laboratories Ltd. Financials

Balance sheet of Vaidya Sane Ayur Lab is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Vaidya Sane Ayur Lab is decreasing.
Latest net debt of Vaidya Sane Ayur Lab is -₹4.91 Crs as of Sep-25.
This is less than Mar-25 when it was -₹3.18 Crs.

Yes, profit is increasing.
The profit of Vaidya Sane Ayur Lab is ₹8.24 Crs for TTM, ₹7.14 Crs for Mar 2025 and ₹1.98 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vaidya Sane Ayur Lab latest dividend payout ratio is 5.44% and 3yr average dividend payout ratio is 5.44%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech